MARKET

HUMAW

Humacyte Inc
HUMAW
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.0035
0.0849
0.0080
-
Humacyte's Symvess Shelf Life Extended To 36 Months Following FDA Authorization
NASDAQ · 22h ago
Humacyte announces FDA extension of expiration dating period for Symvess
TipRanks · 1d ago
Humacyte Receives FDA Authorization To Extend The Expiration Dating Period For Symvess From 18 To 36 Months
Benzinga · 1d ago
Weekly Report: what happened at HUMA last week (0831-0904)?
Weekly Report · 3d ago
Humacyte Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humacyte, Inc. - HUMA
Barchart · 5d ago
Weekly Report: what happened at HUMA last week (0824-0828)?
Weekly Report · 08/31 10:12
Humacyte Earnings Call: Clinical Wins vs Cash Burn
TipRanks · 08/25 00:22
Humacyte confirms plans for ATEV supplemental biologic license application
TipRanks · 08/24 12:05
More

Webull offers Humacyte Inc stock information, including NASDAQ: HUMAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HUMAW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HUMAW stock methods without spending real money on the virtual paper trading platform.